From crippling fatigue to brain fog, CML treatment can affect your body in ways that go beyond the usual side effects.

The FDA granted orphan designation to Sanofi US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Discover th ...

(Reuters) -AstraZeneca will buy longtime partner FibroGen's China unit for about $160 million to gain rights to its anemia ...

AstraZeneca (AZN) is set to acquire U.S. biotech company FibroGen’s (FGEN) China unit for $160 million to expand its presence in the country.

Preoperatively assessing anemia as a modifiable risk factor may counteract increased mortality risk for patients with severe ...